The role of long intergenic noncoding RNA 00511 in malignant tumors: a meta-analysis, database validation and review

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
   Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–289.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhang Y, Gao J, et al. The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data. Bioengineered. 2020;11(1):572–581.
   PubMed Web of Science ®Google Scholar
• Jin KT, Yao J-Y, Fang X-L, et al. Roles of lncRNAs in cancer: focusing on angiogenesis. Life Sci. 2020;252:117647.
   PubMed Web of Science ®Google Scholar
• Han B, Ge Y, Cui j-p, et al. Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis. Bioengineered. 2020;11(1):524–535.
   PubMed Web of Science ®Google Scholar
• Wang B, Wang Y-Z,  Wang K, et al. Expression and clinical significance of lncRNA LINC00511 in plasma exosome of glioma patients. Chin J Pract Nerv Dis. 2019;22(14):1548–1553.
   Google Scholar
• Wang J, Wang S-S, Ma H, et al. Expressions clinical signification and prognostic analysis of linc00511 in ovarian cancer tissues. J Pract Med. 2019;35(16):2584–2591.
   Google Scholar
• Liu L, Zhu Y, Liu A-M, et al. Long noncoding RNA LINC00511 involves in breast cancer recurrence and radioresistance by regulating STXBP4 expression via miR-185. Eur Rev Med Pharmacol Sci. 2019;23(17):7457–7468.
   PubMed Web of Science ®Google Scholar
• Lu G, Li Y, Ma Y, et al. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. J Exp Clin Cancer Res. 2018;37(1):289.
   PubMedGoogle Scholar
• Mao B-DI, Xu P, Zhong Y, et al. LINC00511 knockdown prevents cervical cancer cell proliferation and reduces resistance to paclitaxel. J Biosci. 2019;44(2):44.
   PubMed Web of Science ®Google Scholar
• Yu C-L, Xu X-L, Yuan F. LINC00511 is associated with the malignant status and promotes cell proliferation and motility in cervical cancer. Biosci Rep. 2019;39(9):BSR20190903.
   PubMedGoogle Scholar
• Qiao S-C,  Qi K,  Liu C, et al. Long intergenic non-coding RNA 511 correlates with improved prognosis, and hinders osteosarcoma progression both in vitro and in vivo. J Clin Lab Anal. 2020;34(5):e23164.
   Web of Science ®Google Scholar
• Sun -C-C, Li S-J, Li G, et al. Long intergenic noncoding RNA 00511 acts as an oncogene in non-small-cell lung cancer by binding to EZH2 and suppressing p57. Mol Ther Nucleic Acids. 2016;5(11):e385–e385.
   PubMedGoogle Scholar
• Wang RP, Jiang J, Jiang T, et al. Increased long noncoding RNA LINC00511 is correlated with poor prognosis and contributes to cell proliferation and metastasis by modulating miR-424 in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2019;23(8):3291–3301.
   PubMed Web of Science ®Google Scholar
• Hu P, Cui H, Lei T, et al. Linc00511 indicates a poor prognosis of liver hepatocellular carcinoma. Onco Targets Ther. 2019;12:9367–9376.
   PubMed Web of Science ®Google Scholar
• Hu W-Y, Wei H-Y, Li K-M, et al. LINC00511 as a ceRNA promotes cell malignant behaviors and correlates with prognosis of hepatocellular carcinoma patients by modulating miR-195/EYA1 axis. Biomed Pharmacothe. 2020;121:109642.
   PubMed Web of Science ®Google Scholar
• Deng H, Huang C, Wang Y, et al. LINC00511 promotes the malignant phenotype of clear cell renal cell carcinoma by sponging microRNA-625 and thereby increasing cyclin D1 expression. Aging (Albany NY). 2019;11(16):5975–5991.
   PubMedGoogle Scholar
• Zhao X, Liu Y, Li Z, et al. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. J Cell Mol Med. 2018;22(1):655–667.
   PubMed Web of Science ®Google Scholar
• Chen Z, Wu H, Zhang Z, et al. LINC00511 accelerated the process of gastric cancer by targeting miR-625-5p/NFIX axis. Cancer Cell Int. 2019;19:351.
   PubMed Web of Science ®Google Scholar
• Wang D, Liu K, Chen E. LINC00511 promotes proliferation and invasion by sponging miR-515-5p in gastric cancer. Cell Mol Biol Lett. 2020;25:4.
   PubMed Web of Science ®Google Scholar
• Huang HG, Tang X-L, Huang X-S, et al. Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer. Eur Rev Med Pharmacol Sci. 2020;24(8):4232–4245.
   PubMed Web of Science ®Google Scholar
• Ding J, Yang C, Yang S. LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2. J Oral Pathol Med. 2018;47(5):468–476.
   PubMed Web of Science ®Google Scholar
• Xiang J, Guan Y, Bhandari A, et al. LINC00511 influences cellular proliferation through cyclin-dependent kinases in papillary thyroid carcinoma. J Cancer. 2020;11(2):450–459.
   PubMed Web of Science ®Google Scholar
• Fan Y, Chen J. Clinicopathological significance of survivin expression in patients with cervical cancer: A systematic meta-analysis. Bioengineered. 2017;8(5):511–523.
   PubMed Web of Science ®Google Scholar
• Li C, Liu H, Yang J, et al. Long noncoding RNA LINC00511 induced by SP1 accelerates the glioma progression through targeting miR-124-3p/CCND2 axis. J Cell Mol Med. 2019;23(6):4386–4394.
   PubMed Web of Science ®Google Scholar
• Du X, Tu Y, Liu S, et al. LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop. J Cell Mol Med. 2020;24(2):1474–1487.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhao B, Wang X, et al. LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/CDK6 axis. Life Sci. 2019;228:135–144.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhu G, Bao S, et al. Long non-coding RNA LINC00511 mediates the effects of ESR1 on proliferation and invasion of ovarian cancer through miR-424-5p and miR-370-5p. Cancer Manag Res. 2019;11:10807–10819.
   PubMed Web of Science ®Google Scholar
• Guo W, Yu Q, Zhang M, et al. Long intergenic non-protein coding RNA 511 promotes the progression of osteosarcoma cells through sponging microRNA 618 to upregulate the expression of maelstrom. Aging (Albany NY). 2019;11(15):5351–5367.
   PubMedGoogle Scholar
• Yan L-H, Wu X-K,  Liu Y-X, et al. LncRNA Linc00511 promotes osteosarcoma cell proliferation and migration through sponging miR-765. J Cell Biochem. 2018. DOI:10.1002/jcb.27999
   Web of Science ®Google Scholar
• Zhang J, Sui S, Wu H, et al. The transcriptional landscape of lncRNAs reveals the oncogenic function of LINC00511 in ER-negative breast cancer. Cell Death Dis. 2019;10(8):599.
   PubMedGoogle Scholar
• Zhu FY, Zhang S-R, Wang L-H, et al. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1. Eur Rev Med Pharmacol Sci. 2019;23(19):8377–8390.
   PubMed Web of Science ®Google Scholar
• Chen Y, Bao C, Zhang X, et al. Knockdown of LINC00511 promotes radiosensitivity of thyroid carcinoma cells via suppressing JAK2/STAT3 signaling pathway. Cancer Biol Ther. 2019;20(9):1249–1257.
   PubMed Web of Science ®Google Scholar
• Wang J, Tian Y, Zheng H, et al. An integrated analysis reveals the oncogenic function of lncRNA LINC00511 in human ovarian cancer. Cancer Med. 2019;8(6):3026–3035.
   PubMed Web of Science ®Google Scholar
• Shi Y, Liu M, Huang Y, et al. Promotion of cell autophagy and apoptosis in cervical cancer by inhibition of long noncoding RNA LINC00511 via transcription factor RXRA-regulated PLD1. J Cell Physiol. 2020. DOI:10.1002/jcp.29529
   Web of Science ®Google Scholar
• Jiang L, Xie X, Ding F, et al. Silencing LINC00511 inhibits cell proliferation, migration and EMT via PTEN/AKT/FOXO1 signaling pathway in lung cancer. Biochem Cell Biol. 2019. DOI:10.1139/bcb-2018-0364
   Google Scholar